Background: The aim of this study was to assess the consistency of antiatherosclerotic potential of a combination oral contraceptive steroid (ethinyl estradiol+desogestrel) by rating its effect on the differential expression of the low-density lipoprotein receptor (LDLR) and lectin-like oxidized LDL (LOX-1) receptor.
Study Design: Cells from placental trophoblast cell line (JAR) and differentiated primary placental trophoblast cells isolated from term human placentae were used for this study. Expressions of LOX-1 and LDLR were assessed by immunoblot and immunocytochemistry assays. Differential effects of the constituent steroids in the combination of ethinyl estradiol and desogestrel were verified on the expression profile of the receptors.
Results: Desogestrel opposed the effect of ethinyl estradiol on LOX-1 expression, and when used in combination, the combination oral contraceptive reduced the expression of LOX-1 in contrast to LDLR. The characteristic change in the expressions of LOX-1 and LDLR showed an antiatherosclerotic improvisation at the unique combination of ethinyl estradiol (10 ng/mL) and desogestrel (20 ng/mL).
Conclusion: The aforesaid combination of ethinyl estradiol and desogestrel keeps LOX-1 and LDLR reciprocally expressed in antiatherosclerotic mode.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.contraception.2011.05.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The association between oxidized low-density lipoprotein and cancer: An emerging targeted therapeutic approach?
Bioorg Med Chem Lett
July 2024
Center for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India; Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran; Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address:
Lipids play an important role in varying vital cellular processes including cell growth and division. Elevated levels of low-density lipoprotein (LDL) and oxidized-LDL (ox-LDL), and overexpression of the corresponding receptors including LDL receptor (LDLR), lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), and cluster of differentiation 36 (CD36), have shown strong correlations with different facets of carcinogenesis including proliferation, invasion, and angiogenesis. Furthermore, a high serum level of LOX-1 is considered as a poor prognostic factor in many types of cancer including colorectal cancer.
View Article and Find Full Text PDFHawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-ⅡA signaling in macrophages in mice.
J Ethnopharmacol
June 2024
School of Biomedical Sciences, University of Queensland, St Lucia, Brisbane, Queensland, 4072, Australia. Electronic address:
Ethnopharmacological Relevance: Hawthorn leaves are a combination of the dried leaves of the Rosaceae plants, i.e., Crataegus pinnatifida Bge.
View Article and Find Full Text PDFEfficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.
Front Pharmacol
November 2023
Institute of Basic Medical Sciences, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Lipid-lowering therapy is an important tool for the treatment of lipid metabolic diseases, which are increasing in prevalence. However, the failure of conventional lipid-lowering drugs to achieve the desired efficacy in some patients, and the side-effects of these drug regimens, highlight the urgent need for novel lipid-lowering drugs. The liver and intestine are important in the production and removal of endogenous and exogenous lipids, respectively, and have an important impact on circulating lipid levels.
View Article and Find Full Text PDFLipids and lipoproteins may play a role in the neuropathology of Alzheimer's disease.
Front Neurosci
November 2023
Molecular Cardiology, Vascular and Medicinal Research, The Texas Heart Institute, Houston, TX, United States.
Article Synopsis
- Alzheimer's disease (AD) and dementia pose significant challenges for patients and society due to their complex social, physical, and financial impacts, with the underlying biology of AD still not fully understood despite numerous studies.
- The hypothesis presented suggests that lipids, especially electronegative low-density lipoprotein (L5), play a crucial role in AD's pathophysiology, particularly as changes in lipid levels are observed in affected individuals but not yet properly explained.
- Factors such as mitochondrial dysfunction, blood-brain barrier problems, and inflammation, linked to lipid dysregulation, are believed to contribute to memory loss in AD, indicating that certain lipids and their receptors could serve as potential biomarkers for the disease.
Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation.
Redox Rep
December 2023
Department of Cardiology, Affiliated Hospital of Putian University, Department of Clinical Medicine, Fujian Medical University, Putian, People's Republic of China.
Objective: To investigate the effects of glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide on endothelial dysfunction in LDL receptor-deficient (LDLR-KO) mice and ox-LDL-challenged human umbilical vein endothelial cells (HUVECs) and its possible mechanism.
Methods: LDLR-KO mice were randomly treated with normal saline, liraglutide, or liraglutide plus a GLP-1R antagonist exendin-9 for four weeks. In parallel, HUVECs were cultured with ox-LDL alone or combined with liraglutide, in the presence or absence of lectin-like ox-LDL receptor-1(LOX-1) overexpression or GLP-1R knockdown.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!